Ligand validation:5O9H

OLA: OLEIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5O9H_OLA_A_404	30%	59%	0.22	0.91	0.52	1.03	-	-	0	0	85%	0.85
5O9H_OLA_A_413	29%	74%	0.191	0.911	0.29	0.7	-	-	1	0	65%	0.65
5O9H_OLA_B_419	23%	73%	0.21	0.888	0.28	0.76	-	-	10	0	70%	0.7
5O9H_OLA_B_408	23%	45%	0.162	0.899	0.78	1.34	-	1	0	0	35%	0.35
5O9H_OLA_B_410	19%	60%	0.242	0.835	0.51	1	-	-	3	0	100%	1
5O9H_OLA_B_417	17%	58%	0.25	0.869	0.54	1.04	-	-	3	0	80%	0.8
5O9H_OLA_A_417	16%	60%	0.262	0.836	0.5	1.02	-	-	2	0	100%	1
5O9H_OLA_B_405	16%	57%	0.236	0.854	0.56	1.1	-	1	1	0	75%	0.75
5O9H_OLA_A_414	16%	57%	0.281	0.891	0.55	1.07	-	-	0	0	80%	0.8
5O9H_OLA_B_407	15%	53%	0.251	0.877	0.59	1.21	-	1	0	0	65%	0.65
5O9H_OLA_B_416	13%	62%	0.28	0.825	0.52	0.94	-	-	3	0	100%	1
5O9H_OLA_A_406	12%	74%	0.279	0.859	0.28	0.72	-	-	7	0	75%	0.75
5O9H_OLA_B_415	12%	59%	0.298	0.827	0.51	1.03	-	-	2	0	100%	1
5O9H_OLA_A_407	11%	55%	0.256	0.828	0.6	1.11	-	-	0	0	70%	0.7
5O9H_OLA_A_410	11%	77%	0.218	0.819	0.27	0.64	-	-	0	0	50%	0.5
5O9H_OLA_A_416	10%	61%	0.305	0.816	0.51	0.97	-	-	5	0	100%	1
5O9H_OLA_A_405	9%	60%	0.275	0.772	0.51	0.99	-	-	6	0	100%	1
5O9H_OLA_A_415	9%	73%	0.307	0.844	0.3	0.73	-	-	0	0	75%	0.75
5O9H_OLA_B_414	9%	73%	0.266	0.856	0.31	0.74	-	-	0	0	45%	0.45
5O9H_OLA_B_409	9%	59%	0.309	0.831	0.54	1.01	-	1	1	0	80%	0.8
5O9H_OLA_B_404	7%	51%	0.268	0.814	0.68	1.2	-	-	0	0	50%	0.5
5O9H_OLA_B_403	6%	55%	0.274	0.766	0.6	1.14	-	-	0	0	65%	0.65
5O9H_OLA_B_412	4%	61%	0.362	0.756	0.52	0.97	-	-	1	0	100%	1
5O9H_OLA_B_411	4%	56%	0.34	0.766	0.59	1.09	-	-	0	0	70%	0.7
5O9H_OLA_A_409	4%	74%	0.365	0.798	0.31	0.69	-	-	1	0	60%	0.6
5O9H_OLA_B_418	3%	58%	0.373	0.772	0.56	1.04	-	-	0	0	75%	0.75
5O9H_OLA_A_412	3%	59%	0.462	0.818	0.5	1.07	-	1	2	0	100%	1
5O9H_OLA_B_406	3%	54%	0.406	0.804	0.59	1.16	-	1	4	0	70%	0.7
5O9H_OLA_A_418	3%	52%	0.408	0.821	0.65	1.19	-	1	0	0	55%	0.55
5O9H_OLA_A_408	2%	58%	0.452	0.783	0.54	1.06	-	-	1	0	80%	0.8
5O9H_OLA_B_413	2%	55%	0.473	0.806	0.59	1.13	-	-	1	0	70%	0.7
5O9H_OLA_A_411	2%	58%	0.506	0.802	0.52	1.06	-	1	1	0	90%	0.9
6DJ6_OLA_B_402	92%	68%	0.081	0.971	0.55	0.69	-	-	0	0	100%	1
1LFO_OLA_A_128	79%	59%	0.097	0.943	0.78	0.79	1	-	0	0	100%	1
8GEW_OLA_A_202	64%	57%	0.138	0.938	0.69	0.94	-	2	0	0	100%	0.44
5IU4_OLA_A_2406	64%	62%	0.105	0.903	0.69	0.75	-	1	0	0	100%	1
7V3K_OLA_D_401	55%	65%	0.16	0.928	0.6	0.74	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.